Lacosamide Medical Valley 100 mg Norveġja - Norveġiż - Statens legemiddelverk

lacosamide medical valley 100 mg

medical valley invest ab - lakosamid - tablett, filmdrasjert - 100 mg

Lacosamide Medical Valley 50 mg Norveġja - Norveġiż - Statens legemiddelverk

lacosamide medical valley 50 mg

medical valley invest ab - lakosamid - tablett, filmdrasjert - 50 mg

Lacosamide Medical Valley 150 mg Norveġja - Norveġiż - Statens legemiddelverk

lacosamide medical valley 150 mg

medical valley invest ab - lakosamid - tablett, filmdrasjert - 150 mg

Lacosamide Medical Valley 200 mg Norveġja - Norveġiż - Statens legemiddelverk

lacosamide medical valley 200 mg

medical valley invest ab - lakosamid - tablett, filmdrasjert - 200 mg

Lacosamide Accord Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

lacosamide accord

accord healthcare s.l.u. - lakosamid - epilepsi - antiepileptics, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Lacosamide UCB Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

lacosamide ucb

ucb pharma s.a. - lakosamid - epilepsier, delvis - antiepileptics, - lacosamide ucb er indisert som monoterapi og tilleggsbehandling ved behandling av delvis-utbruddet anfall med eller uten sekundær generalisering hos voksne, ungdom og barn fra 4 år med epilepsi.

Lacosamide Adroiq Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lakosamid - epilepsi - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Lamivudine/Zidovudine Teva Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

lamivudine/zidovudine teva

teva pharma b.v.  - lamivudine, zidovudine - hiv-infeksjoner - antivirale midler til systemisk bruk - lamivudin / zidovudin teva er angitt i antiretroviral kombinationsbehandling for behandling av hiv-infeksjon (human immunodeficiency virus).

Brinzolamid/Brimonidin Medical Valley 10 mg/ ml / 2 mg/ ml Norveġja - Norveġiż - Statens legemiddelverk

brinzolamid/brimonidin medical valley 10 mg/ ml / 2 mg/ ml

medical valley invest ab - brinzolamid / brimonidintartrat - Øyedråper, suspensjon - 10 mg/ ml / 2 mg/ ml

Brinzolamid/Timolol Medical Valley 10 mg/ ml / 5 mg/ ml Norveġja - Norveġiż - Statens legemiddelverk

brinzolamid/timolol medical valley 10 mg/ ml / 5 mg/ ml

medical valley invest ab - brinzolamid / timololmaleat - Øyedråper, suspensjon - 10 mg/ ml / 5 mg/ ml